{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:05:48Z","timestamp":1789103148319,"version":"build-2803163510"},"reference-count":34,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/21645515.2026.2714602","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:07:44Z","timestamp":1789099664000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Trends in HPV vaccination among adults aged 27\u201345 years in the United States"],"prefix":"10.1080","volume":"22","author":[{"given":"Marcie","family":"Fisher-Borne","sequence":"first","affiliation":[{"name":"Merck & Co., Inc.","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolae","family":"Done","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc.","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Eiden","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salini","family":"Mohanty","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Wang","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc.","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anyu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc.","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Sears","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc.","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Patterson-Lomba","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc.","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Song","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc.","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika L.","family":"Thompson","sequence":"additional","affiliation":[{"name":"The University of Texas at San Antonio","place":["San Antonio, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"e_1_3_5_2_1","unstructured":"Centers for Disease Control and Prevention. Human papillomavirus (HPV): clinical overview. Updated 2024 Apr 30 [accessed 2024 Sep 15]. https:\/\/www.cdc.gov\/hpv\/hcp\/clinical-overview\/index.html."},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6733a2"},{"key":"e_1_3_5_4_1","unstructured":"Centers for Disease Control and Prevention. Cancers caused by HPV. 2025 Mar 3 [accessed 2026 Aug 5]. https:\/\/www.cdc.gov\/hpv\/about\/cancers-caused-by-hpv.html."},{"key":"e_1_3_5_5_1","unstructured":"Centers for Disease Control and Prevention. Cancers linked with HPV each year. 2025 Dec 3 [accessed 2026 Jan 28]. https:\/\/www.cdc.gov\/cancer\/hpv\/cases.html."},{"key":"e_1_3_5_6_1","unstructured":"American Cancer Society. Key statistics for cervical cancer. 2026 Jan 14 [accessed 2026 Jan 28]. https:\/\/www.cancer.org\/cancer\/types\/cervical-cancer\/about\/key-statistics.html."},{"key":"e_1_3_5_7_1","volume-title":"Gardasil (human papillomavirus quadrivalent [types 6, 11, 16, and 18] vaccine, recombinant). Prescribing information.","author":"US Food and Drug Administration","year":"2006","unstructured":"US Food and Drug Administration. Gardasil (human papillomavirus quadrivalent [types 6, 11, 16, and 18] vaccine, recombinant). Prescribing information. Silver Spring (MD): US Food and Drug Administration; 2006."},{"issue":"2","key":"e_1_3_5_8_1","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Centers for Disease Control and Prevention","year":"2007","unstructured":"Centers for Disease Control and Prevention. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep. 2007;56(RR\u20132):1\u201324.","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_3_5_9_1","unstructured":"US Food and Drug Administration. Cervarix (human papillomavirus bivalent [Types 16 and 18] vaccine recombinant). Prescribing information. Silver Spring (MD): US Food and Drug Administration; 2009."},{"issue":"20","key":"e_1_3_5_10_1","first-page":"626","article-title":"FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","unstructured":"Centers for Disease Control and Prevention. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep. 2010;59(20):626\u2013629.","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_3_5_11_1","volume-title":"Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant). Prescribing information.","author":"US Food and Drug Administration","year":"2014","unstructured":"US Food and Drug Administration. Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant). Prescribing information. Silver Spring (MD): US Food and Drug Administration; 2014."},{"issue":"11","key":"e_1_3_5_12_1","first-page":"300","article-title":"Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices","volume":"64","author":"Petrosky E","year":"2015","unstructured":"Petrosky E, Bocchini JA Jr, Hariri S, Chesson, H, Curtis, CR, Saraiya, M, Unger, ER, Markowitz, LE. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. Morb Mortal Wkly Rep. 2015;64(11):300\u2013304.","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_3_5_13_1","unstructured":"FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old. Silver Spring (MD): PRNewswire; 2018 Oct 5 [accessed 2024 Sep 15]. https:\/\/www.prnewswire.com\/news-releases\/fda-approves-expanded-use-of-gardasil-9-to-include-individuals-27-through-45-years-old-300725424.html."},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6832a3"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2024.107951"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2313249"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2025.108180"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2022.4716"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.39258"},{"key":"e_1_3_5_20_1","unstructured":"KFF. The HPV vaccine: access and use in the U.S. 2024 Aug 5 [accessed 2024 Sep 15]. https:\/\/www.kff.org\/womens-health-policy\/fact-sheet\/the-hpv-vaccine-access-and-use-in-the-u-s\/."},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2381283"},{"issue":"3","key":"e_1_3_5_22_1","first-page":"150","article-title":"Comparison of pharmacists and primary care providers as immunizers","volume":"1","author":"Bowers DA","year":"2009","unstructured":"Bowers DA, Shafrin J. Comparison of pharmacists and primary care providers as immunizers. Am J Pharm. 2009;1(3):150\u2013157.","journal-title":"Am J Pharm"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1660119"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2022.101893"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2024.2441255"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10900-021-00968-3"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2021.01.200408"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.02.051"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.whi.2022.01.007"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/19325037.2020.1844102"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.01.053"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab111"},{"key":"e_1_3_5_33_1","volume-title":"Estimating the age of disease-causal HPV infection based on the natural history of CIN2+ among females in Canada","author":"Cherif A","year":"2025","unstructured":"Cherif A, You X, Hillhouse E, Stone RC, Murphy B, Baluni G, Yadav M, Gotarkar S, Reuschenbach M, Chen YT, et al. Estimating the age of disease-causal HPV infection based on the natural history of CIN2+ among females in Canada. Oxford University Press US; 2025."},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix475"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djz227"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2026.2714602","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/21645515.2026.2714602","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2026.2714602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:07:47Z","timestamp":1789099667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2026.2714602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/21645515.2026.2714602"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2026.2714602","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-04-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2714602"}}